Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia

Conditions

• Community Acquired Bacterial Pneumonia
• Complicated Intra-Abdominal Infection

Interventions

• DRUG: Tigecycline
• DRUG: Tigecycline
• DRUG: cIAI: Ceftriaxone with metronidazole, plus if applicable aminoglycoside
• DRUG: CAP: Ceftriaxone, plus if applicable oral clarithromycin

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer